SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Stockman Scott's Political Debate Porch -- Ignore unavailable to you. Want to Upgrade?


To: H James Morris who wrote (9813)12/3/2002 12:00:43 PM
From: stockman_scott  Respond to of 89467
 
In the Money

seattlepi.nwsource.com

Dexterra Inc.

Amount: $6 million during the week of 12/2/2002

Dexterra Inc., a maker of enterprise software, has raised $6 million in a first round of funding from Silicon Valley venture capital firm Sigma Partners.

The Bothell company also named co-founder and chairman Robert Loughan as chief executive officer.

Loughan previously co-founded Octane Software, which was sold to E.piphany for $3.2 billion in 2000.

Dexterra’s software is used to bring sales, marketing and service information to employees working in the field. The software works with Pocket PC devices that are based on Microsoft’s .Net initiative.

Previously known as Accompany-ME Technology, Dexterra was spun out of business incubator Gryphon Labs earlier this year.

Related URL: dexterra.com



To: H James Morris who wrote (9813)12/6/2002 8:54:25 AM
From: stockman_scott  Read Replies (1) | Respond to of 89467
 
Venture Capital: Intrepid start-ups hitting the Rolodexes

By JOHN COOK
SEATTLE POST-INTELLIGENCER REPORTER
Friday, December 6, 2002

Corporate spending on technology remains in the gutter, and recent reports indicate that it may not get much better next year.

So how do early-stage start-ups -- without the name recognition of a Microsoft or IBM -- sell unproven technology products to wary corporations?

That's a question many entrepreneurs are struggling with as the tech slump enters its third year.

Pitching new software or networking equipment is not easy these days. But a few courageous start-ups, which only recently began revving up the marketing engines, hope they can succeed amid one of the worst climates in the technology industry.

Bellevue-based Consera, a 9-month-old start-up that is developing software to help corporations better manage data centers, is one of those companies. It plans to release its first product -- Dynamic Resource Manager -- early next year.

Founded by a group of former Microsoft technologists and backed by Ignition, Consera is trying to thaw the icy business climate at Fortune 500 companies by marketing its software as a cost-saving necessity.

It's a common tactic.

With technology budgets squeezed and chief information officers under pressure, Consera says it can ease the financial strain now plaguing information technology departments.

Companies "are not just throwing money out there, they are being deliberate about their spending," said Pamela Roussos, vice president of marketing at Consera. "But the fact is, they are still spending, so if you can show that you can save them money," it can result in sales.

Consera's management team also is relying on contacts from previous work experience, primarily at Microsoft, to get in the door at larger companies. Chief Executive Officer Frank Artale spent nine years at Microsoft, including a stint as general manager of the Windows 2000 group. Four of the five top managers at the start-up have roots that go back to the software giant.

"A lot of it now is relationship-based ," said Roussos, the former CEO at 555-1212.com. "If we were sitting in front of a room of entrepreneurs giving advice, we would tell them to go to their Rolodex and really work the relationships."

That's something that Vizx Labs founder Tom Ranken is doing. An Immunex veteran and former president of the Washington Biotechnology & Biomedical Association, Ranken is chatting up friends at the University of Washington and the Fred Hutchinson Cancer Research Center about his company's 2-month-old bioinformatics software.

Ranken admits that it is difficult to market the product -- dubbed GeneSifter -- without much cash. But he has found ways to get in front of the scientists and researchers who would potentially use the technology.

In addition to phone calls and meetings with established contacts, Ranken is sending members of his 11-person company to trade shows and conferences at a rate of about one per month. Next week it's a cell biology conference in San Francisco.

The company also caught a recent break when a Japanese company agreed to distribute and market GeneSifter in Asia. While a little bit of luck played a part in sealing the deal, Ranken said the partnership "has worked out great so far." Now, Ranken is trying to do something similar in North America and Europe.

Three years ago, Ranken said, his company probably would have been attending every conference, hiring dozens of business development staff members and coordinating advertising campaigns in an effort to win customers.

Now, because of the high-tech slow down, he said, the goals of the company are more modest.

"The strategy here is not to take over the world in the next six weeks but rather to bootstrap the company and the product," said Ranken, who raised $1 million in angel financing in September. "Our immediate goal is to reach cash flow positive, not to build $100 million in sales that costs us $250 million to get there."

That sort of business focus is also motivating Gwen Spertell, the recently appointed chief executive of Bellevue-based Intelligent Results. Spertell, who joined the maker of data analysis software in October, only recently began marketing the company's first product.

While Spertell said the lack of corporate spending "is a big problem for the whole industry," she is confident that niche markets can be carved out in certain industries.

That's why her company recently decided to switch from a broad-based marketing approach to one that focused only on financial institutions.

As part of that effort, Spertell recently turned down a business contract with a consumer products company because it did not fit the company's target customer base.

Turning down business in this market is tough to do. But Spertell said it is necessary for a small company with a tiny sales force.

"You can't let yourself get too splintered because then you can't deliver," said Spertell, whose company employs 38 people. "It is not easy but you have to learn how to say no. Learning how to say no is just as important as saying yes."

Intelligent Results, with six customers, has relied on other tactics to drive sales.

Like many venture-backed start-ups, company executives are using board members from Ignition and OVP Venture Partners to make introductions. Those contacts recently resulted in a series of meetings with a major West Coast bank, Spertell said.

Still, not every start-up has venture capitalists working on its behalf. And even if they all did, those connections don't necessarily translate into sales in an environment where few corporations are taking risks on new technology.

Some reports in recent days have suggested that sales of computer chips, security software and other technologies may be improving.

But a report last week by Deloitte & Touche found that 85 percent of venture capitalists expect technology spending to remain stagnant for the next 12 months. Recent studies by Gartner and IDC found that technology spending in the United States will shrink or grow only slightly next year.

That's not good news for start-up companies with limited track records.

But Roussos, for one, is prepared for the challenge.

"At a start-up, nothing is ever easy," she said. "So you have to be mentally prepared to go through the difficult times."

seattlepi.nwsource.com



To: H James Morris who wrote (9813)12/13/2002 12:44:08 PM
From: stockman_scott  Respond to of 89467
 
Venture Capital: The state of the regional market from 3 who know

By JOHN COOK
SEATTLE POST-INTELLIGENCER REPORTER
Friday, December 13, 2002

Alan Frazier, Alex Knight and Chad Waite are three of the most seasoned venture capitalists in Seattle, with more than 40 years of experience among them.

Together, their firms have raised more than $2 billion and backed more than 200 start-up companies.

So when the three men spoke at PricewaterhouseCoopers' seventh annual venture capital panel this week, they had the attention of entrepreneurs, bankers and lawyers who wanted to know which way the wind is blowing in the Seattle start-up community.

Knight, who joined the Seattle office of Arch Venture Partners in 1997, painted a bleak picture. In his view, Seattle's day in the spotlight has come and gone.

"I am a pessimist on Seattle right now," said Knight, who sits on the boards of Classmates Online, Nimble Technology and Syncronex. "Seattle got hit hard and probably harder than most areas."

He said it has become increasingly difficult to recruit management talent here, partly because of the weather but also because of the lack of economic diversity. Seattle voters, he said, have proved over and over again that they don't want to improve the region's deteriorating infrastructure or step up and become a big city.

"Seattle is a small town, and it likes to be a small town, and I don't think it is going to change," said Knight. "The Northwest region has some challenges." Among those he cited were a broken transportation network and poor fiscal policies.

Paradoxically, Knight's comments were made the same week that a study found that Seattle is the most competitive city in the country. That study, compiled by the Beacon Hill Institute at Suffolk University in Boston, pointed directly to the city's strength in venture capital, new company creation and educated employees.

But if venture capitalists such as Knight, whose firm has offices in Albuquerque, N.M., Austin, Texas, Chicago and New York, start redirecting money to other markets, it could be bad news for Seattle. And that souring attitude could send a reeling technology community into a deeper spiral.

Venture capital investments plummeted 39 percent in the third quarter, with only one first-round deal being completed in the state.

Alan Frazier isn't as pessimistic about Seattle's future, saying "it is still a vibrant enough economy and fun place to live."

But the former Immunex executive, who founded Frazier & Co. in 1991 and now manages more than $750 million, admits that the start-up community -- especially in health care -- lags behind Northern and Southern California.

"When we start a new company in San Diego or the Bay Area, they have the experience," said Frazier. "In Seattle, we don't have that critical mass."

Attempts must be made to broaden the economy beyond The Boeing Co. and Microsoft Corp., he said. That's something his firm is trying to do by placing bets on early-stage biotechnology and medical-device companies such as GeneCraft and Calypso Medical Technologies.

OVP's Chad Waite, who has nearly a quarter-century of venture capital experience, said there are "slim pickings" in health care and biotechnology in the Pacific Northwest. That led OVP to stop making investments in the sector earlier this year, a decision also motivated by lackluster returns.

But the software industry -- anchored by Microsoft -- is a different story, he said. There are still plenty of opportunities to find interesting software companies, although Waite's firm has made only one new investment this year.

"I am not worried at all about deal flow in Seattle," said Waite. "I am in the business of making three to four deals a year, so we are not looking for 15 projects that we are going to invest in."

The three venture capitalists also spent a little time commenting on the venture capital industry itself, which is suffering from negative returns, limited liquidity events and other hangovers from the dot-com bust.

All three VCs said a more classic approach to venture capital is being employed.

That means building companies over the long-term and focusing on how much cash a company needs to reach break even.

Partnering with other venture firms, known as syndication, also is an important tactic in this climate because it cuts down on risk, they said.

"We've come back to a stunning remembrance of what it is to start a company," said Waite.

Frazier agreed, saying that with valuations falling and the investment pace slowing, "it is back to basics" again.

"It is a fun time," said Frazier. "We are all in venture capital because we want to grow new businesses, so we are being asked to roll up our sleeves."

seattlepi.nwsource.com